BioSpace News Archive

Zevra Therapeutics, Inc. has announced that it will host a conference call and live audio webcast on Monday, August 14, 2023, at 8:30 a.m. ET, to review its corporate and financial results for the second quarter of 2023.

Cognition Therapeutics, Inc. today announced that the Company will release financial results for the second quarter on Tuesday, August 8, 2023 before the market opens.

Oramed Pharmaceuticals Inc. announced that it has signed a non-binding term sheet with Hefei Tianhui Biotech Co., Ltd. to establish a joint venture based on Oramed’s oral drug delivery technology.

Surmodics, Inc., a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, reported financial results for its third quarter ended June 30, 2023, and updated its financial guidance for its fiscal year ending September 30, 2023.

Recce Pharmaceuticals Ltd, the Company developing a new class of synthetic anti-infectives, is pleased to announce the international cash receipt of A$98,428.27 from the government of Canada as part of its Scientific Research and Experimental Development tax incentive program.

Aquestive Therapeutics, Inc. announced today that the management team will participate in the 2023 Wedbush PacGrow Healthcare Conference in New York.

Faron Pharmaceuticals Ltd. announces that the Company’s Chief Executive Officer, Dr. Markku Jalkanen, and Chief Medical Officer, Dr. Marie-Louise Fjällskog, will participate in a fireside chat at the Canaccord Genuity 43rd Annual Growth Conference on Thursday, August 10, 2023 at 12:30-12:55 PM Eastern Time at the InterContinental Boston Hotel in Boston, Massachusetts, in Room Abigail Adams C.

Candel Therapeutics, Inc. today announced that Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer, will participate in a fireside chat at the upcoming Canaccord Genuity 43rd Annual Growth Conference, taking place August 7-10, 2023, in Boston.

Cue Biopharma, Inc. announced today that it will host a conference call and webcast to provide a business and clinical update on Wednesday, August 9, 2023 at 4:30 p.m. EDT.

ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursday, August 10, 2023, at 11:00 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2023 and provide a business update.